Cyprotex
Emma Poole is a Scientist II at Cyprotex with experience in developing conjugated polymer nanoparticles antibody conjugates for a novel biomedical imaging platform. Prior to this, Emma worked as a Research Associate at The University of Manchester and as a Laboratory Demonstrator at the University of Leeds. With a PhD in Chemistry from the University of Leeds and a Master's degree from the University of Hull, Emma's expertise lies in nanomaterials and nanomaterial characterization.
This person is not in any offices
Cyprotex
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology